mHealth Technology and CVD Risk Reduction

Maan Isabella Cajita; Yaguang Zheng; Jacob Kigo Kariuki; Karen M Vuckovic; Lora E Burke

doi:10.1007/s11883-021-00927-2

mHealth Technology and CVD Risk Reduction

Maan Isabella Cajita, Yaguang Zheng, Jacob Kigo Kariuki, Karen M Vuckovic, Lora E Burke

Research output: Contribution to journal › Review article › peer-review

Abstract

PURPOSE OF REVIEW: To review existing mHealth-based interventions and examine their efficacy in reducing cardiovascular disease (CVD) risk factors.

RECENT FINDINGS: A total of 50 articles are included in this review. The majority of the mHealth interventions targeted a specific CVD risk factor, while 4 addressed 2 or more CVD risk factors. Of the 9 mHealth-supported weight loss intervention trials, 4 resulted in significant weight loss. Four out of 7 RCTs targeting improvement in physical activity reported significant improvement, while 4 of the 8 mHealth-supported smoking cessation intervention trials resulted in smoking abstinence. Of the 10 mHealth-based diabetes intervention trials, 5 reported significant reductions in HbA1c; however, only 3 out of the 9 antihypertension interventions resulted in significant reductions in blood pressure. There is a growing body of literature focused on mHealth interventions that address CVD risk factors. Despite the immense potential of mHealth interventions, evidence of their efficacy in mitigating cardiovascular risk is heterogeneous.

Original language	English (US)
Article number	36
Pages (from-to)	36
Journal	Current atherosclerosis reports
Volume	23
Issue number	7
DOIs	https://doi.org/10.1007/s11883-021-00927-2
State	Published - Jul 2021

Keywords

CVD risk factors
Cardiovascular disease
Physical activity
Smoking
Weight loss
mHealth

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1007/s11883-021-00927-2

Cite this

@article{02dc8b2c5ed2469c921a0d63876b6db8,

title = "mHealth Technology and CVD Risk Reduction",

abstract = "PURPOSE OF REVIEW: To review existing mHealth-based interventions and examine their efficacy in reducing cardiovascular disease (CVD) risk factors.RECENT FINDINGS: A total of 50 articles are included in this review. The majority of the mHealth interventions targeted a specific CVD risk factor, while 4 addressed 2 or more CVD risk factors. Of the 9 mHealth-supported weight loss intervention trials, 4 resulted in significant weight loss. Four out of 7 RCTs targeting improvement in physical activity reported significant improvement, while 4 of the 8 mHealth-supported smoking cessation intervention trials resulted in smoking abstinence. Of the 10 mHealth-based diabetes intervention trials, 5 reported significant reductions in HbA1c; however, only 3 out of the 9 antihypertension interventions resulted in significant reductions in blood pressure. There is a growing body of literature focused on mHealth interventions that address CVD risk factors. Despite the immense potential of mHealth interventions, evidence of their efficacy in mitigating cardiovascular risk is heterogeneous.",

keywords = "CVD risk factors, Cardiovascular disease, Physical activity, Smoking, Weight loss, mHealth",

author = "Cajita, {Maan Isabella} and Yaguang Zheng and Kariuki, {Jacob Kigo} and Vuckovic, {Karen M} and Burke, {Lora E}",

note = "Funding Information: MIC is supported by a Clinical and Translational Science Scholarship (KL2TR002002). LEB is partially supported by grants from the National Institutes of Health (R01 HL131583-01A1, R01 HL135218, R21MD013490, R01 NINR016710-01A1). JKK is supported by a diversity supplement from the National Heart, Lung, and Blood Institute (NHLBI HL107370S). Publisher Copyright: {\textcopyright} 2021, This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.",

year = "2021",

month = jul,

doi = "10.1007/s11883-021-00927-2",

language = "English (US)",

volume = "23",

pages = "36",

journal = "Current atherosclerosis reports",

issn = "1523-3804",

publisher = "Current Medicine Group",

number = "7",

}

TY - JOUR

T1 - mHealth Technology and CVD Risk Reduction

AU - Cajita, Maan Isabella

AU - Zheng, Yaguang

AU - Kariuki, Jacob Kigo

AU - Vuckovic, Karen M

AU - Burke, Lora E

N1 - Funding Information: MIC is supported by a Clinical and Translational Science Scholarship (KL2TR002002). LEB is partially supported by grants from the National Institutes of Health (R01 HL131583-01A1, R01 HL135218, R21MD013490, R01 NINR016710-01A1). JKK is supported by a diversity supplement from the National Heart, Lung, and Blood Institute (NHLBI HL107370S). Publisher Copyright: © 2021, This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

PY - 2021/7

Y1 - 2021/7

N2 - PURPOSE OF REVIEW: To review existing mHealth-based interventions and examine their efficacy in reducing cardiovascular disease (CVD) risk factors.RECENT FINDINGS: A total of 50 articles are included in this review. The majority of the mHealth interventions targeted a specific CVD risk factor, while 4 addressed 2 or more CVD risk factors. Of the 9 mHealth-supported weight loss intervention trials, 4 resulted in significant weight loss. Four out of 7 RCTs targeting improvement in physical activity reported significant improvement, while 4 of the 8 mHealth-supported smoking cessation intervention trials resulted in smoking abstinence. Of the 10 mHealth-based diabetes intervention trials, 5 reported significant reductions in HbA1c; however, only 3 out of the 9 antihypertension interventions resulted in significant reductions in blood pressure. There is a growing body of literature focused on mHealth interventions that address CVD risk factors. Despite the immense potential of mHealth interventions, evidence of their efficacy in mitigating cardiovascular risk is heterogeneous.

AB - PURPOSE OF REVIEW: To review existing mHealth-based interventions and examine their efficacy in reducing cardiovascular disease (CVD) risk factors.RECENT FINDINGS: A total of 50 articles are included in this review. The majority of the mHealth interventions targeted a specific CVD risk factor, while 4 addressed 2 or more CVD risk factors. Of the 9 mHealth-supported weight loss intervention trials, 4 resulted in significant weight loss. Four out of 7 RCTs targeting improvement in physical activity reported significant improvement, while 4 of the 8 mHealth-supported smoking cessation intervention trials resulted in smoking abstinence. Of the 10 mHealth-based diabetes intervention trials, 5 reported significant reductions in HbA1c; however, only 3 out of the 9 antihypertension interventions resulted in significant reductions in blood pressure. There is a growing body of literature focused on mHealth interventions that address CVD risk factors. Despite the immense potential of mHealth interventions, evidence of their efficacy in mitigating cardiovascular risk is heterogeneous.

KW - CVD risk factors

KW - Cardiovascular disease

KW - Physical activity

KW - Smoking

KW - Weight loss

KW - mHealth

UR - http://www.scopus.com/inward/record.url?scp=85105839490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85105839490&partnerID=8YFLogxK

U2 - 10.1007/s11883-021-00927-2

DO - 10.1007/s11883-021-00927-2

M3 - Review article

C2 - 33983491

SN - 1523-3804

VL - 23

SP - 36

JO - Current atherosclerosis reports

JF - Current atherosclerosis reports

IS - 7

M1 - 36

ER -

mHealth Technology and CVD Risk Reduction

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this